| Code | Descripción | Paquete |
|---|---|---|
| PDM016 | Bcl-2 Oncoprotein | 6ml |
| A00004.0025 | Bcl-2 Oncoprotein; Clone 124 | 25 ml |
| A00004 | Bcl-2 Oncoprotein; Clone 124 | 6 ml |
| A20004 | Bcl-2 Oncoprotein; Clone 124 | 2 ml |
| 61-0005 | Bcl-2, Antibody | 1 ml |
| 60-0005-7 | Bcl-2, Antibody | 7 ml |
| 61-0005-5 | Bcl-2, Antibody | 0,5 ml |
| 61-0005-2 | Bcl-2, Antibody | 0,2 ml |
| A00119-C | Bcl-2; Clone 100/D5 (Concentrate) | 1 ml |
| A00119-0025 | Bcl-2; Clone 100/D5 (Ready-To-Use) | 25 ml |
| A00119-0007 | Bcl-2; Clone 100/D5 (Ready-To-Use) | 7 ml |
| A00119-0002 | Bcl-2; Clone 100/D5 (Ready-To-Use) | 2 ml |
| AC-0242 | Bcl-6 | 1 ml |
| PDM229 | Bcl-6 (Follicular Lymphoma Marker) | 6 ml |
| PDM229-25 | Bcl-6 (Follicular Lymphoma Marker) | 25 ml |
| RA0024-C.5 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Concentrate) | 0.5 ml |
| RA0024-C.1 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Concentrate) | 0.1 ml |
| A00077.0025 | Bcl-6; Clone PG-B6p | 25 ml |
| A00077 | Bcl-6; Clone PG-B6p | 6 ml |
| A20077 | Bcl-6; Clone PG-B6p | 2 ml |
| Mob442-05 | Bcl-X | 0.5ml |
| Mob442 | Bcl-X | 1ml |
| RA0022-C.5 | Bcl-X (Apoptosis Marker); Clone 2H12 (Concentrate) | 0.5 ml |
| RA0022-C.1 | Bcl-X (Apoptosis Marker); Clone 2H12 (Concentrate) | 0.1 ml |
| RA0023-C.5 | Bcl-X (Apoptosis Marker); Clone BX006 & 2H12 (Concentrate) | 0.5 ml |
| RA0023-C.1 | Bcl-X (Apoptosis Marker); Clone BX006 & 2H12 (Concentrate) | 0.1 ml |
| RA0021-C.5 | Bcl-X (Apoptosis Marker); Clone BX006 (Concentrate) | 0.5 ml |
| RA0021-C.1 | Bcl-X (Apoptosis Marker); Clone BX006 (Concentrate) | 0.1 ml |
| RA0347-C.5 | BCL10 (MALT-Lymphoma Marker); Clone BL10/411 (Concentrate) | 0.5 ml |
| RA0347-C.1 | BCL10 (MALT-Lymphoma Marker); Clone BL10/411 (Concentrate) | 0.1 ml |
| RA0424-C.5 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/1118 (Concentrate) | 0.5 ml |
| RA0425-C.5 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/961 (Concentrate) | 0.5 ml |
| RA0425-C.1 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/961 (Concentrate) | 0.1 ml |
| RP080-05 | Beta-Catenin | 0.5ml |
| RP080 | Beta-Catenin | 1ml |
| AC-0034 | Beta-Catenin | 1 ml |
| RA0104-C.5 | beta-Catenin (p120); Rabbit Polyclonal (Concentrate) | 0.5 ml |
| RA0104-C.1 | beta-Catenin (p120); Rabbit Polyclonal (Concentrate) | 0.1 ml |
| AC-0168RUO | BMI-1 | 0,1 ml |
| MOB424-05 | BRCA1 | 0.5ml |
| MOB424 | BRCA1 | 1ml |
| RA0378-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone 85-2C8 (Concentrate) | 0.5 ml |
| RA0378-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone 85-2C8 (Concentrate) | 0.1 ml |
| RA0377-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD.3 (Concentrate) | 0.5 ml |
| RA0377-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD.3 (Concentrate) | 0.1 ml |
| RA0372-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD469 (Concentrate) | 0.5 ml |
| RA0372-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD469 (Concentrate) | 0.1 ml |
| RA0374-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD494 (Concentrate) | 0.5 ml |
| RA0374-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD494 (Concentrate) | 0.1 ml |
| RA0375-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BU20a (Concentrate) | 0.5 ml |
